ARQT Exercise Disclosure
Matsuda Masaru · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$0
Matsuda Masaru EVP, Chief Legal Officer
ARQT
Transaction date
Nov 4, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed same day
ARQT daily price context
Close on/before transaction
$34.05
Nov 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 40,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-070385
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.56M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Nov 4, 2026 | $145.6K |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Nov 4, 2026 | $1.37M |
| Arcutis Biotherapeutics, Inc. ARQT Current | Exercise | Nov 4, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Nov 2, 2026 | $38.84K |